Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

9 Big Pharmas With The Least Side Effects
Seeking Alpha
Monday, September 26, 2011 - 10:57am
tags:
Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, GSK, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
Human Genome Spikes On Sales: Good Time To Consider Buying
Seeking Alpha
Monday, September 26, 2011 - 10:56am
tags:
Human Genome Sciences, GSK, Benlysta, lupus
Teva Tumbles to Lowest Since 2006 on EU Review of Cephalon
BusinessWeek
Sunday, September 25, 2011 - 1:12pm
tags:
Teva Pharmaceuticals, Cephalon
Ireland Beckons Biotech Business
Chemical and Engineering News
Sunday, September 25, 2011 - 1:09pm
tags:
Ireland
Paladin Considers Options Following Alternate Offer for Afexa
Stock Markets Review
Sunday, September 25, 2011 - 1:08pm
tags:
Paladin, Afexa, Valeant Pharmaceuticals, M&A
Debunking Corporate Venture Capital in Biotech
Forbes
Sunday, September 25, 2011 - 1:05pm
tags:
venture capital
Johnson & Johnson's Xarelto Not a Cure for Pipeline Concerns
Seeking Alpha
Sunday, September 25, 2011 - 1:05pm
tags:
JNJ, Xarelto
Siga's Setback Promises Gains For PharmAthene
Seeking Alpha
Sunday, September 25, 2011 - 12:59pm
tags:
PharmAthene, SIGA technologies
Anything Positive At Enzon?
Seeking Alpha
Sunday, September 25, 2011 - 12:58pm
tags:
Enzon
T-DM1 Significantly Improved Progression-Free Survival Compared to Standard of Care for Previously Untreated HER2-Positive Metastatic Breast Cancer
Yahoo/GlobeNewswire
Sunday, September 25, 2011 - 12:57pm
tags:
trastuzumab, T-DM1, breast cancer, Immunogen
8 Underperforming Biotech Stocks Being Bought by the Smart Money
Seeking Alpha
Sunday, September 25, 2011 - 12:55pm
tags:
Amyris, NPS Pharmaceuticals, Targacept, Sequenom, Cadence Pharmaceuticals, Enzon, Dendreon, Incyte
Novartis cutting 2,500 jobs globally
Reuters
Saturday, September 24, 2011 - 1:29pm
tags:
Novartis
First Phase III trial of an alpha-pharmaceutical
eurekalert.org
Saturday, September 24, 2011 - 1:26pm
tags:
Bone metastases, prostate cancer, Alpharadin, Algeta, Bayer
U.S. FDA guidance on biosimilars may be imminent
HealthNews
Saturday, September 24, 2011 - 1:21pm
tags:
FDA, biosimilars
Teva announces pharmaceutical sales deal with Washington-based CDI
medreps
Saturday, September 24, 2011 - 1:18pm
tags:
Teva Pharmaceuticals, Cocrystal Discovery Incorporated, anti-viral, hepatitis C
Isis Pharma files patent suit against Santaris
North Country Times, CA
Saturday, September 24, 2011 - 1:16pm
tags:
Isis Pharmaceuticals, Santaris
Fitch Downgrades Pfizer’s Debt
Barron's
Saturday, September 24, 2011 - 1:14pm
tags:
Pfizer
Generic Drugs Continue To Challenge Big Pharma
Seeking Alpha
Saturday, September 24, 2011 - 1:12pm
tags:
generics
Bristol-Myers Signs Deal
Yahoo/Zacks
Saturday, September 24, 2011 - 1:11pm
tags:
Bristol-Myers Squibb, Ambrx, Fibroblast Growth Factor 21, FGF-21, Relaxin, diabetes
Healthcare: 8 Safe Bets For Dividends And Great Returns
Seeking Alpha
Saturday, September 24, 2011 - 12:52pm
tags:
Abbot, Merck, Eli Lilly, JNJ, Bristol-Myers Squibb, Novartis, Pfizer, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.